04.06.2013 Views

Teste de control la obstetrica si ginecologie in limba engleza pentru ...

Teste de control la obstetrica si ginecologie in limba engleza pentru ...

Teste de control la obstetrica si ginecologie in limba engleza pentru ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Teste</strong> <strong>de</strong> <strong>control</strong> <strong>la</strong> <strong>obstetrica</strong> <strong>si</strong> <strong>g<strong>in</strong>ecologie</strong> <strong>in</strong> <strong>limba</strong> <strong>engleza</strong> <strong>pentru</strong> examenul<br />

<strong>de</strong> absolvire, anul VI<br />

COMPLEMENT SIMPLU<br />

1. How common is preec<strong>la</strong>mp<strong>si</strong>a?<br />

a. most pregnant women <strong>de</strong>velop preec<strong>la</strong>mp<strong>si</strong>a<br />

b. about 25% of all women <strong>de</strong>velop preec<strong>la</strong>mp<strong>si</strong>a<br />

c. about 15% of all women <strong>de</strong>velop preec<strong>la</strong>mp<strong>si</strong>a<br />

d. about 3-5% of all women <strong>de</strong>velop preec<strong>la</strong>mp<strong>si</strong>a<br />

e. very rare<br />

d<br />

2. What is the <strong>de</strong>f<strong>in</strong>ition of an antepartum hemorrhage?<br />

a. any vag<strong>in</strong>al hemorrhage between conception and <strong>de</strong>livery<br />

b. any vag<strong>in</strong>al hemorrhage dur<strong>in</strong>g <strong>la</strong>bor<br />

c. any vag<strong>in</strong>al hemorrhage between 28 weeks gestation and onset of <strong>la</strong>bor<br />

d. any vag<strong>in</strong>al hemorrhage between 12 weeks gestation and <strong>de</strong>livery<br />

e. any vag<strong>in</strong>al hemorrhage between 28 weeks gestation and <strong>de</strong>livery<br />

c<br />

3. What is the most likely cause of a mas<strong>si</strong>ve antepartum hemorrhage that threatens the<br />

mother’s life?<br />

a. rupture of the uterus<br />

b. cervical carc<strong>in</strong>oma<br />

c. trauma of the uterus<br />

d. p<strong>la</strong>centa praevia<br />

e. p<strong>la</strong>centa acretta<br />

d<br />

4. Which of the follow<strong>in</strong>g will exclu<strong>de</strong> a p<strong>la</strong>centa praevia?<br />

a. a careful speculum exam<strong>in</strong>ation<br />

b. a careful abdom<strong>in</strong>al exam<strong>in</strong>ation<br />

c. the presence of fetal distress<br />

d. a vag<strong>in</strong>al exam<strong>in</strong>ation <strong>in</strong> theatre<br />

e. pa<strong>in</strong>less bleed<strong>in</strong>g<br />

d<br />

5. Preterm pre<strong>la</strong>bor rupture of the membranes is <strong>de</strong>f<strong>in</strong>ed as:<br />

a. membranes that have ruptured at term, and not been followed by the onset of <strong>la</strong>bor with<strong>in</strong> 24<br />

hours


. membranes that rupture before the second stage of <strong>la</strong>bor<br />

c. membranes that rupture before the active phase of <strong>la</strong>bor<br />

d. membranes that have ruptured before 37 weeks, <strong>in</strong> the absence of contractions<br />

e. membranes that have ruptured before the onset of <strong>la</strong>bor at any gestational age<br />

d<br />

6. Which patients are at highest risk of preterm <strong>la</strong>bor?<br />

a. patients who book early <strong>in</strong> pregnancy<br />

b. multigravidas<br />

c. patients liv<strong>in</strong>g <strong>in</strong> low socio-economic circumstances<br />

d. patients with vulvovag<strong>in</strong>itis<br />

e. patients with a history of preterm <strong>la</strong>bor <strong>in</strong> previous pregnancy<br />

e<br />

7. ß – mimetics (terbutal<strong>in</strong>, ritodr<strong>in</strong>) should not be used <strong>in</strong> a patient with:<br />

a. asthma<br />

b. preterm <strong>la</strong>bor<br />

c. multiple pregnancy<br />

d. breech presentation<br />

e. heart valve disease<br />

e<br />

8. The most appropriate tocolitic drug is con<strong>si</strong><strong>de</strong>red:<br />

a. terbutal<strong>in</strong><br />

b. magne<strong>si</strong>um sulphate<br />

c. <strong>in</strong>dometac<strong>in</strong><br />

d. nifedip<strong>in</strong><br />

e. ritodr<strong>in</strong><br />

d<br />

9. Indometac<strong>in</strong> may be more dangerous to the fetus if given at or beyond:<br />

a. 30 weeks<br />

b. 33 weeks<br />

c. 35 weeks<br />

d. 37 weeks<br />

e. 39 weeks<br />

a<br />

10. ß – mimetics should be used with grate caution <strong>in</strong> the follow<strong>in</strong>g patients, except:<br />

a. with heart diseases<br />

b. with diabetes


c. with antepartum hemorrhage<br />

d. with pyrexia<br />

e. with asthma<br />

e<br />

11. How often should the fetal heart rate be monitored dur<strong>in</strong>g the first stage of <strong>la</strong>bor <strong>in</strong> low risk<br />

pregnancies?<br />

a. every 3 hours dur<strong>in</strong>g the <strong>la</strong>tent phase<br />

b. every 2 hours <strong>in</strong> the <strong>la</strong>tent phase<br />

c. hourly <strong>in</strong> the active phase<br />

d. every 30 m<strong>in</strong>utes <strong>in</strong> the active phase<br />

e. every 15 m<strong>in</strong>utes <strong>in</strong> the active phase<br />

d<br />

12. Meconium sta<strong>in</strong><strong>in</strong>g of the liquor is commonest <strong>in</strong>:<br />

a. patients with postterm <strong>la</strong>bor<br />

b. patients <strong>in</strong> term <strong>la</strong>bor<br />

c. patients <strong>in</strong> preterm <strong>la</strong>bor<br />

d. patients whose fetuses move a lot dur<strong>in</strong>g pregnancy<br />

e. patients with fetuses > 4000 gr<br />

a<br />

13. Meconium sta<strong>in</strong><strong>in</strong>g of the liquor:<br />

a. is uncommon<br />

b. occurs <strong>in</strong> 10-20 % of patients<br />

c. occurs <strong>in</strong> 30-40% of patients<br />

d. occurs <strong>in</strong> half of patients<br />

e. occurs <strong>in</strong> most patients<br />

b<br />

14. What is the correct management when the liquor is meconium sta<strong>in</strong>ed?<br />

a. monitor the fetal heart rate carefully<br />

b. <strong>de</strong>liver the fetus immediately by cesarean section<br />

c. give the patient an oxitoc<strong>in</strong> <strong>in</strong>fu<strong>si</strong>on to shorten the <strong>la</strong>bor<br />

d. give tocolitics<br />

e. adm<strong>in</strong>ister antibiotics<br />

a<br />

15. The <strong>la</strong>tent phase of the first stage of <strong>la</strong>bor is:<br />

a. the period of time the cervix takes to di<strong>la</strong>te from 3 cm to full di<strong>la</strong>tation<br />

b. the period of time from the onset of <strong>la</strong>bor to full cervical di<strong>la</strong>tation


c. the period of time from the onset of <strong>la</strong>bor to 3 cm cervical di<strong>la</strong>tation<br />

d. the period of time dur<strong>in</strong>g which the cervix becomes effaced<br />

e. the period of time dur<strong>in</strong>g which the cervix becomes ripen.<br />

C<br />

16. A patient presents <strong>in</strong> established <strong>la</strong>bor with regu<strong>la</strong>r contractions. On vag<strong>in</strong>al exam<strong>in</strong>ation the<br />

cervix is 5 cm di<strong>la</strong>ted. Where should her cervical di<strong>la</strong>tation be noted on the partogram?<br />

a. on the alert l<strong>in</strong>e oppo<strong>si</strong>te 5 cm cervical di<strong>la</strong>tation<br />

b. on the action l<strong>in</strong>e oppo<strong>si</strong>te 5 cm cervical di<strong>la</strong>tation<br />

c. at the beg<strong>in</strong>n<strong>in</strong>g of the <strong>la</strong>tent phase of <strong>la</strong>bor oppo<strong>si</strong>te 5 cm cervical di<strong>la</strong>tation<br />

d. at the end of <strong>la</strong>tent phase of <strong>la</strong>bor oppo<strong>si</strong>te 5 cm cervical di<strong>la</strong>tation<br />

e. on the vertical l<strong>in</strong>e at the beg<strong>in</strong>n<strong>in</strong>g of the active phase of <strong>la</strong>bor oppo<strong>si</strong>te 5 cm cervical<br />

di<strong>la</strong>tation<br />

a<br />

17. When does a patient have a<strong>de</strong>quate and effective uter<strong>in</strong>e contractions ?<br />

a. if she has 2 or more contractions every 10 m<strong>in</strong>utes with each contraction <strong>la</strong>st<strong>in</strong>g 30 seconds<br />

or longer<br />

b. if she has 3 or more contractions every 10 m<strong>in</strong>utes with each contraction <strong>la</strong>st<strong>in</strong>g 60 seconds<br />

or longer<br />

c. if she progresses normally dur<strong>in</strong>g <strong>la</strong>bor<br />

d. if she has pa<strong>in</strong> with every contraction<br />

e. if the uterus is re<strong>la</strong>xed between each contraction<br />

c<br />

18. Cephalo-pelvic disproportion due to a small pelvic <strong>in</strong>let should be diagnosed when:<br />

a. there is no further di<strong>la</strong>tation of the cervix<br />

b. there is 3/5 or more of the fetal head palpable above the pelvic brim and 2+ or more<br />

mould<strong>in</strong>g is present<br />

c. there is 2/5 or less of the fetal head palpable above the pelvic brim and 1+ mould<strong>in</strong>g is<br />

present<br />

d. the measurement of pelvic <strong>in</strong>let are assessed as small dur<strong>in</strong>g a pelvic exam<strong>in</strong>ation<br />

e. one hour passed after full di<strong>la</strong>tation<br />

b<br />

19. When does the second stage of <strong>la</strong>bor beg<strong>in</strong> and end?<br />

a. from the time the patient has an urge to bear down until the <strong>in</strong>fant is completely <strong>de</strong>livered<br />

b. from the time the cervix is fully di<strong>la</strong>ted until the <strong>in</strong>fant is completely <strong>de</strong>livered<br />

c. from the beg<strong>in</strong>n<strong>in</strong>g of the active phase until the cervix is fully di<strong>la</strong>ted<br />

d. from the beg<strong>in</strong>n<strong>in</strong>g of the active phase until the <strong>in</strong>fant is completely <strong>de</strong>livered.<br />

e. from the time the cervix is fully di<strong>la</strong>ted until <strong>de</strong>livery of the fetus and p<strong>la</strong>centa


20. What po<strong>si</strong>tion <strong>in</strong> the second stage of <strong>la</strong>bor should be discouraged<br />

a. the dorsal po<strong>si</strong>tion<br />

b. the <strong>la</strong>teral po<strong>si</strong>tion<br />

c. the squatt<strong>in</strong>g po<strong>si</strong>tion<br />

d. the <strong>si</strong>tt<strong>in</strong>g po<strong>si</strong>tion (<strong>in</strong> the special chair)<br />

e. the kneel<strong>in</strong>g po<strong>si</strong>tion<br />

a<br />

21. The active phase of the first stage of <strong>la</strong>bor is:<br />

a. the period of time the cervix takes to di<strong>la</strong>te from 3 cm to full di<strong>la</strong>tation<br />

b. the period of time from the onset of <strong>la</strong>bor to full cervical di<strong>la</strong>tation<br />

c. the period of time from the onset of <strong>la</strong>bor to 3 cm cervical di<strong>la</strong>tation<br />

d. the period of time dur<strong>in</strong>g which the cervix becomes effaced<br />

e. the period of time dur<strong>in</strong>g which the cervix becomes ripen.<br />

a<br />

22. Which drug is not used for prevention of postpartum hemorrhage<br />

a. oxitoc<strong>in</strong>e<br />

b. ergometr<strong>in</strong>e<br />

c. carboprost<br />

d. ritodr<strong>in</strong><br />

e. syntometr<strong>in</strong>e<br />

d<br />

23. Pas<strong>si</strong>ve management of the third stage of <strong>la</strong>bor <strong>in</strong>clu<strong>de</strong>s:<br />

a. giv<strong>in</strong>g an oxytocic and then wait<strong>in</strong>g for the <strong>si</strong>ghs of p<strong>la</strong>cental separation<br />

b. wait<strong>in</strong>g for the <strong>si</strong>gns of p<strong>la</strong>cental separation when the patient is asked to bear down and<br />

spontaneously <strong>de</strong>liver the p<strong>la</strong>centa<br />

c. pull<strong>in</strong>g down steadily on the umbilical cord and push<strong>in</strong>g the uterus up when the patient has a<br />

contraction<br />

d. giv<strong>in</strong>g an oxytocic drug when the <strong>si</strong>gns of p<strong>la</strong>cental separation appear so that the p<strong>la</strong>centa<br />

can be spontaneously <strong>de</strong>livered<br />

e. early cord c<strong>la</strong>mp<strong>in</strong>g, use of oxytocic drug and <strong>control</strong>led cord traction<br />

b<br />

24. What cl<strong>in</strong>ical f<strong>in</strong>d<strong>in</strong>gs <strong>in</strong>dicate that the bleed<strong>in</strong>g is from a tear?<br />

a. the bleed<strong>in</strong>g con<strong>si</strong>sts of a cont<strong>in</strong>uous stream of bright red blood<br />

b. the uterus is atonic an abdom<strong>in</strong>al palpation<br />

c. the patient is shocked and pale


d. dark red clots of blood are passed when the uterus is rubbed up.<br />

e. fragments of p<strong>la</strong>centa are mis<strong>si</strong>ng<br />

a<br />

25. What is the probable diagno<strong>si</strong>s of a patient sud<strong>de</strong>nly becomes shocked without any <strong>si</strong>gn of<br />

vag<strong>in</strong>al bleed<strong>in</strong>g dur<strong>in</strong>g the third stage of <strong>la</strong>bor and on abdom<strong>in</strong>al exam<strong>in</strong>ation the uterus<br />

cannot be palpated?<br />

a. an atonic uterus<br />

b. a ruptured uterus<br />

c. an <strong>in</strong>verted uterus<br />

d. a cervical tear<br />

e. p<strong>la</strong>centa acretta<br />

c<br />

26. What is the most frequent cause of postpartum hemorrhage:<br />

a. cervical and vag<strong>in</strong>al tears<br />

b. uter<strong>in</strong>e rupture<br />

c. DIC syndrome<br />

d. Coagulopathy<br />

e. Uter<strong>in</strong>e atonia<br />

e<br />

27. What is the first step <strong>in</strong> the management of a postpartum hemorrhage when the p<strong>la</strong>centa has<br />

already be <strong>de</strong>livered?<br />

a. the uterus must be immediately rubbed up<br />

b. a rapid <strong>in</strong>travenous <strong>in</strong>fu<strong>si</strong>on of 40 units of oxitoc<strong>in</strong> should be started<br />

c. the patient’s b<strong>la</strong>d<strong>de</strong>r must be emptied<br />

d. the cause of bleed<strong>in</strong>g must be looked for<br />

e. the hematocrit, hemoglob<strong>in</strong> and blood group should be <strong>de</strong>term<strong>in</strong>ed<br />

a<br />

28. Which <strong>si</strong>gn suggest that an atonic uterus causes the bleed<strong>in</strong>g?<br />

a. the vag<strong>in</strong>al bleed<strong>in</strong>g con<strong>si</strong>sts of a cont<strong>in</strong>uous stream of bright red blood<br />

b. the membrane are not complete<br />

c. the vag<strong>in</strong>al bleed<strong>in</strong>g is <strong>in</strong>termittent and con<strong>si</strong>st of dark red clots<br />

d. no uterus can be palpated an abdom<strong>in</strong>al exam<strong>in</strong>ations<br />

e. <strong>si</strong>gns of shock and acute abdomen are present<br />

c<br />

29. Which cl<strong>in</strong>ical <strong>si</strong>gn suggests that the patient has acute pyelonephritis?<br />

a. ten<strong>de</strong>rness over the b<strong>la</strong>d<strong>de</strong>r


. e<strong>de</strong>ma<br />

c. severe ten<strong>de</strong>rness to percus<strong>si</strong>on over one or both renal angles<br />

d. severe ten<strong>de</strong>rness <strong>in</strong> the upper abdomen<br />

e. pa<strong>in</strong> <strong>in</strong> the lower abdomen<br />

c<br />

30. What hormone is <strong>de</strong>term<strong>in</strong>ed <strong>in</strong> ur<strong>in</strong>e for diagno<strong>si</strong>s of pregnancy?<br />

a. pro<strong>la</strong>ct<strong>in</strong><br />

b. p<strong>la</strong>cental <strong>la</strong>ctogen<br />

c. chorionic gonadotrop<strong>in</strong>e<br />

d. progesteron<br />

e. oxytoc<strong>in</strong>e<br />

c<br />

31. In what disor<strong>de</strong>r the level of chorionic gonadotrop<strong>in</strong>e is abnormally high?<br />

a. ectopic pregnancy<br />

b. preec<strong>la</strong>mp<strong>si</strong>a<br />

c. threatened abortion<br />

d. tw<strong>in</strong> pregnancy<br />

e. trophob<strong>la</strong>stic disease<br />

e<br />

32. In what disor<strong>de</strong>r the level of chorionic gonadotrop<strong>in</strong>e is abnormally low?<br />

a. ectopic pregnancy<br />

b. preec<strong>la</strong>mp<strong>si</strong>a<br />

c. fetal growth retardation<br />

d. tw<strong>in</strong> pregnancy<br />

e. trophob<strong>la</strong>stic disease<br />

a<br />

33. Severe anemia <strong>in</strong> pregnant women is diagnosed if the level of hemoglob<strong>in</strong> is below:<br />

a. 110 gr/l<br />

b. 100 gr/l<br />

c. 90 gr/l<br />

d. 70 gr/l<br />

e. 40 gr/l<br />

d<br />

34. The amniotic fluid <strong>in</strong><strong>de</strong>x represents:


a. the total of the l<strong>in</strong>ear measurements of the <strong>la</strong>rgest amniotic fluid pockets noted on ultrasonic<br />

<strong>in</strong>spection of each of the four quadrants of the gestational sac<br />

b. the total of the l<strong>in</strong>ear measurements of the four <strong>la</strong>rgest amniotic fluid pockets noted on<br />

ultrasonic <strong>in</strong>spection<br />

c. the sum of the length of the two <strong>la</strong>rgest pockets of amniotic fluid<br />

d. the sum of the length of the three <strong>la</strong>rgest pockets of amniotic fluid<br />

e. the total of the l<strong>in</strong>ear measurements of the <strong>la</strong>rgest amniotic fluid pockets noted on ultrasonic<br />

<strong>in</strong>spection of each half (superior and <strong>in</strong>ferior) of the gestational sac<br />

a<br />

35. Oligohydramnios can be <strong>de</strong>f<strong>in</strong>ed as an amniotic fluid <strong>in</strong><strong>de</strong>x of less than:<br />

a. 10 cm<br />

b. 7 cm<br />

c. 6 cm<br />

d. 5 cm<br />

e. 2 cm<br />

d<br />

36. Polihydramnios can be <strong>de</strong>f<strong>in</strong>ed as an amniotic fluid <strong>in</strong><strong>de</strong>x of more than:<br />

a. 8 cm<br />

b. 10 cm<br />

c. 15 cm<br />

d. 18 cm<br />

e. 23 cm<br />

e<br />

37. The causes of polyhydramnios are the follow<strong>in</strong>g, except:<br />

a. maternal diabetes<br />

b. absence of esophagus<br />

c. neural tube <strong>de</strong>fects<br />

d. thoracic tumors<br />

e. renal agene<strong>si</strong>s<br />

e<br />

38. A reactive non-stress is con<strong>si</strong><strong>de</strong>red when:<br />

a. a <strong>la</strong>te acceleration is observed after each contraction<br />

b. a <strong>la</strong>te acceleration is observed only once<br />

c. a <strong>la</strong>te <strong>de</strong>celeration is observed after each contraction<br />

d. at least two accelerations of fetal heart rate of 15 beats or more above the basel<strong>in</strong>e or at least<br />

15 seconds are observed dur<strong>in</strong>g 20 m<strong>in</strong>utes<br />

e. an acceleration of fetal heart rate of 15 beats or more above the basel<strong>in</strong>e for at least 15<br />

seconds is observed is observed dur<strong>in</strong>g 20 m<strong>in</strong>utes


d<br />

39. What is the <strong>la</strong>rgest part of the true pelvis:<br />

a. the pelvic <strong>in</strong>let<br />

b. the p<strong>la</strong>ne of greatest diameter<br />

c. mid-p<strong>la</strong>ne<br />

d. upper p<strong>la</strong>ne<br />

e. the pelvic outlet<br />

b<br />

40. The anterio-posterior diameter of 11-11,5 cm and transversal diameter of 13-13,5 cm is<br />

characteristic for:<br />

a. the pelvic <strong>in</strong>let<br />

b. the p<strong>la</strong>ne of greatest diameter<br />

c. mid-p<strong>la</strong>ne<br />

d. upper p<strong>la</strong>ne<br />

e. the pelvic outlet<br />

a<br />

41. The anterio-posterior diameter of 12,5-12,75 cm and transversal diameter of 12,5 cm is<br />

characteristic for:<br />

a. the pelvic <strong>in</strong>let<br />

b. the p<strong>la</strong>ne of greatest diameter<br />

c. mid-p<strong>la</strong>ne<br />

d. upper p<strong>la</strong>ne<br />

e. the pelvic outlet<br />

b<br />

42. The anterio-posterior diameter of 11-12 cm and transversal diameter of 10,5 cm is<br />

characteristic for:<br />

a. the pelvic <strong>in</strong>let<br />

b. the p<strong>la</strong>ne of greatest diameter<br />

c. midp<strong>la</strong>ne<br />

d. upper p<strong>la</strong>ne<br />

e. the pelvic outlet<br />

c<br />

43. An <strong>in</strong>ci<strong>si</strong>on of per<strong>in</strong>eum is named:<br />

a. <strong>la</strong>biotomy<br />

b. epi<strong>si</strong>otomy


c. lobotomy<br />

d. <strong>si</strong>nciputotomy<br />

e. peritoneotomy<br />

b<br />

44. A per<strong>in</strong>eal <strong>la</strong>ceration that extends <strong>in</strong>to the subepithelial tissues of the vag<strong>in</strong>a or per<strong>in</strong>eum<br />

with or without <strong>in</strong>volvement of the muscles of the per<strong>in</strong>eal body is <strong>de</strong>f<strong>in</strong>ed as:<br />

a. first <strong>de</strong>gree per<strong>in</strong>eal <strong>la</strong>ceration<br />

b. second <strong>de</strong>gree per<strong>in</strong>eal <strong>la</strong>ceration<br />

c. third <strong>de</strong>gree per<strong>in</strong>eal <strong>la</strong>ceration<br />

d. fourth <strong>de</strong>gree per<strong>in</strong>eal <strong>la</strong>ceration<br />

e. fifth <strong>de</strong>gree per<strong>in</strong>eal <strong>la</strong>ceration<br />

b<br />

45. A per<strong>in</strong>eal <strong>la</strong>ceration <strong>in</strong>volv<strong>in</strong>g the anal sph<strong>in</strong>cter, without rectal mucosa is <strong>de</strong>f<strong>in</strong>ed as:<br />

a. first <strong>de</strong>gree per<strong>in</strong>eal <strong>la</strong>ceration<br />

b. second <strong>de</strong>gree per<strong>in</strong>eal <strong>la</strong>ceration<br />

c. third <strong>de</strong>gree per<strong>in</strong>eal <strong>la</strong>ceration<br />

d. fourth <strong>de</strong>gree per<strong>in</strong>eal <strong>la</strong>ceration<br />

e. fifth <strong>de</strong>gree per<strong>in</strong>eal <strong>la</strong>ceration<br />

c<br />

46. A per<strong>in</strong>eal <strong>la</strong>ceration <strong>in</strong>volv<strong>in</strong>g the rectal mucosa is <strong>de</strong>f<strong>in</strong>ed as:<br />

a. first <strong>de</strong>gree per<strong>in</strong>eal <strong>la</strong>ceration<br />

b. second <strong>de</strong>gree per<strong>in</strong>eal <strong>la</strong>ceration<br />

c. third <strong>de</strong>gree per<strong>in</strong>eal <strong>la</strong>ceration<br />

d. fourth <strong>de</strong>gree per<strong>in</strong>eal <strong>la</strong>ceration<br />

e. fifth <strong>de</strong>gree per<strong>in</strong>eal <strong>la</strong>ceration<br />

d<br />

47. Likelihood of successful <strong>in</strong>duction of <strong>la</strong>bor is assessed u<strong>si</strong>ng:<br />

a. Bishop score<br />

b. Apgar score<br />

c. Silverman score<br />

d. Dunkan score<br />

e. Lucas score<br />

a<br />

48. Condition of a newborn <strong>in</strong>fant is <strong>de</strong>term<strong>in</strong>ed u<strong>si</strong>ng:<br />

a. Bishop score<br />

b. Apgar score


c. Silverman score<br />

d. Dunkan score<br />

e. Lucas score<br />

b<br />

49. The most efficient <strong>in</strong>tervention <strong>in</strong> improv<strong>in</strong>g outcomes of preterm <strong>de</strong>livered babies is:<br />

a. adm<strong>in</strong>istration of antibiotics<br />

b. tocoli<strong>si</strong>s<br />

c. corticosteroids<br />

d. adm<strong>in</strong>istration of surfactant<br />

e. thyroid hormones treatment<br />

c<br />

50. The fetus with postmaturity syndrome has he follow<strong>in</strong>g, except:<br />

a. loss of subcutaneous fat<br />

b. long f<strong>in</strong>gernails<br />

c. dry, peel<strong>in</strong>g sk<strong>in</strong><br />

d. abundant hair<br />

e. abundant vernix caseosa<br />

e<br />

51. Requirements for forceps application are the follow<strong>in</strong>g, except:<br />

a. fetal head is fully engaged<br />

b. absence of feto-pelvic disproportion<br />

c. the cervix is fully di<strong>la</strong>ted<br />

d. empty b<strong>la</strong>d<strong>de</strong>r<br />

e. unruptured amniotic membranes<br />

e<br />

52. The most frequent complication of pregnancy <strong>in</strong> women with heart diseases is:<br />

a. spontaneous abortion<br />

b. premature <strong>de</strong>livery<br />

c. fetal growth retardation<br />

d. pielonefritis<br />

e. hepatitis<br />

c<br />

53. All of the follow<strong>in</strong>g complications occur most often <strong>in</strong> the third trimester EXCEPT:<br />

a. premature <strong>la</strong>bor<br />

b. cervical <strong>in</strong>competence<br />

c. premature rupture of membranes


d. abruptio p<strong>la</strong>centa<br />

e. round ligament pa<strong>in</strong><br />

e<br />

54. Which of the follow<strong>in</strong>g statements best <strong>de</strong>scribes a footl<strong>in</strong>g breech presentation?<br />

a. the legs and thighs of the fetus are flexed<br />

b. the legs are exten<strong>de</strong>d, and the thighs are flexed<br />

c. the arms, legs, and thighs are completely flexed<br />

d. the legs and thighs are exten<strong>de</strong>d<br />

e. none of the above<br />

d<br />

55. What is the most appropriate management <strong>in</strong> case of failure of present<strong>in</strong>g part to <strong>de</strong>scend <strong>in</strong><br />

the presence of a<strong>de</strong>quate <strong>la</strong>bor?<br />

a. forceps <strong>de</strong>livery<br />

b. cesarean section<br />

c. oxitoc<strong>in</strong> adm<strong>in</strong>istration<br />

d. prostag<strong>la</strong>nd<strong>in</strong> adm<strong>in</strong>istration<br />

e. vacuum extraction<br />

b<br />

56. What is the most appropriate management <strong>in</strong> case of poor progress of cervical di<strong>la</strong>tation and<br />

rare contractions <strong>in</strong> the first period of <strong>la</strong>bor?<br />

a. forceps <strong>de</strong>livery<br />

b. cesarean section<br />

c. oxitoc<strong>in</strong> adm<strong>in</strong>istration<br />

d. prostag<strong>la</strong>nd<strong>in</strong> adm<strong>in</strong>istration<br />

e. vacuum extraction<br />

c<br />

57. What is the most appropriate management <strong>in</strong> case of fetal hypoxia at the end of the second<br />

stage of <strong>la</strong>bor?<br />

a. forceps <strong>de</strong>livery<br />

b. cesarean section<br />

c. oxitoc<strong>in</strong> adm<strong>in</strong>istration<br />

d. prostag<strong>la</strong>nd<strong>in</strong> adm<strong>in</strong>istration<br />

e. vacuum extraction<br />

e<br />

58. Diagno<strong>si</strong>s of pregnancy is based on <strong>de</strong>term<strong>in</strong>ation of:<br />

a. human chorionic gonadotrop<strong>in</strong> (hCG)


. pro<strong>la</strong>ct<strong>in</strong><br />

c. human chorionic somatomammotrop<strong>in</strong> (hCS)<br />

d. progesterone<br />

a<br />

59. Pregnancy ma<strong>in</strong>tenance is based on action of:<br />

a. human chorionic gonadotrop<strong>in</strong> (hCG)<br />

b. pro<strong>la</strong>ct<strong>in</strong><br />

c. human chorionic somatomammotrop<strong>in</strong> (hCS)<br />

d. progesterone<br />

e. estriol<br />

d<br />

60. Lactation is stimu<strong>la</strong>ted by:<br />

a. human chorionic gonadotrop<strong>in</strong> (hCG)<br />

b. pro<strong>la</strong>ct<strong>in</strong><br />

c. human chorionic somatomammotrop<strong>in</strong> (hCS)<br />

d. progesterone<br />

e. estriol<br />

b<br />

61. Involution of the uterus <strong>in</strong> postpartum period is <strong>in</strong>duced by:<br />

a. prostag<strong>la</strong>nd<strong>in</strong><br />

b. pro<strong>la</strong>ct<strong>in</strong><br />

c. oxytoc<strong>in</strong><br />

d. progesterone<br />

e. estriol<br />

c<br />

62. Which of the substance stimu<strong>la</strong>tes gap-junction formation:<br />

a. prostag<strong>la</strong>nd<strong>in</strong><br />

b. <strong>in</strong>dometac<strong>in</strong><br />

c. oxytoc<strong>in</strong><br />

d. progesterone<br />

e. magne<strong>si</strong>um sulfate<br />

a<br />

63. Which of the substance prevents gap-junction formation:<br />

a. prostag<strong>la</strong>nd<strong>in</strong><br />

b. <strong>in</strong>dometac<strong>in</strong><br />

c. oxytoc<strong>in</strong>


d. progesterone<br />

e. magne<strong>si</strong>um sulfate<br />

d<br />

64. Which of the substance may produce premature closure of ductusarteriosus:<br />

a. prostag<strong>la</strong>nd<strong>in</strong><br />

b. <strong>in</strong>dometac<strong>in</strong><br />

c. oxytoc<strong>in</strong><br />

d. progesterone<br />

e. magne<strong>si</strong>um sulfate<br />

b<br />

65. Which of the follow<strong>in</strong>g is a common reservoir of toxop<strong>la</strong>smo<strong>si</strong>s?<br />

a. school-age children<br />

b. bird dropp<strong>in</strong>gs<br />

c. cats<br />

d. contam<strong>in</strong>ated seafood<br />

e. blood<br />

c<br />

66. Which of the follow<strong>in</strong>g is a common reservoir of HIV?<br />

a. school-age children<br />

b. bird dropp<strong>in</strong>gs<br />

c. cats<br />

d. contam<strong>in</strong>ated seafood<br />

e. blood<br />

e<br />

67. Indications for a cesarean section <strong>in</strong>clu<strong>de</strong> all of the follow<strong>in</strong>g EXCEPT:<br />

a. previous cesarean section<br />

b. failed forceps <strong>de</strong>livery<br />

c. fetal distress<br />

d. cervical cerc<strong>la</strong>ge<br />

e. cord pro<strong>la</strong>pse<br />

d<br />

68. Prerequi<strong>si</strong>tes for a forceps <strong>de</strong>livery <strong>in</strong>clu<strong>de</strong> all of the follow<strong>in</strong>g EXCEPT:<br />

a. a completely di<strong>la</strong>ted cervix<br />

b. an empty b<strong>la</strong>d<strong>de</strong>r<br />

c. the vertex <strong>in</strong> the occiput anterior po<strong>si</strong>tion<br />

d. ruptured membranes


e. the known po<strong>si</strong>tion of the vertex<br />

c<br />

69. What is <strong>in</strong>dicated for prevention of respiratory distress syndrome <strong>in</strong> premature neonates:<br />

a. hepar<strong>in</strong><br />

b. oxitoc<strong>in</strong><br />

c. <strong>de</strong>xametazon<br />

d. magne<strong>si</strong>um sulphate<br />

e. prostag<strong>la</strong>nd<strong>in</strong><br />

c<br />

70. What is <strong>in</strong>dicated for <strong>la</strong>bor augmentation:<br />

a. hepar<strong>in</strong><br />

b. oxitoc<strong>in</strong><br />

c. <strong>de</strong>xametazon<br />

d. magne<strong>si</strong>um sulphate<br />

e. prostag<strong>la</strong>nd<strong>in</strong><br />

b<br />

71. What is <strong>in</strong>dicated for prevention thromboembolic complications after cesarean section:<br />

a. hepar<strong>in</strong><br />

b. oxitoc<strong>in</strong><br />

c. <strong>de</strong>xametazon<br />

d. magne<strong>si</strong>um sulphate<br />

e. prostag<strong>la</strong>nd<strong>in</strong><br />

a<br />

72. What is <strong>in</strong>dicated for preparation of cervix for <strong>in</strong>duction of <strong>la</strong>bor:<br />

a. hepar<strong>in</strong><br />

b. oxitoc<strong>in</strong><br />

c. <strong>de</strong>xametazon<br />

d. magne<strong>si</strong>um sulphate<br />

e. prostag<strong>la</strong>nd<strong>in</strong><br />

e<br />

73. What is <strong>in</strong>dicated for treatment of ec<strong>la</strong>mp<strong>si</strong>a:<br />

a. hepar<strong>in</strong><br />

b. oxitoc<strong>in</strong><br />

c. <strong>de</strong>xametazon<br />

d. magne<strong>si</strong>um sulphate<br />

e. prostag<strong>la</strong>nd<strong>in</strong>


d<br />

74. What is <strong>in</strong>dicated to stop premature uter<strong>in</strong>e contractions:<br />

a. Hepar<strong>in</strong><br />

b. oxitoc<strong>in</strong><br />

c. <strong>de</strong>xametazon<br />

d. nifedip<strong>in</strong>e<br />

e. prostag<strong>la</strong>nd<strong>in</strong><br />

d<br />

75. The <strong>in</strong>terval between alert and action l<strong>in</strong>e on WHO partograph is:<br />

a. 1 hour<br />

b. 2 hours<br />

c. 3 hours<br />

d. 4 hours<br />

e. 5 hours<br />

d<br />

76. Accord<strong>in</strong>g to WHO partograph <strong>la</strong>tent phase should not be more than:<br />

a. 4 hours<br />

b. 6 hours<br />

c. 8 hours<br />

d. 10 hours<br />

e. 12 hours<br />

C<br />

77. Characteristics of the androgen <strong>in</strong>sen<strong>si</strong>tivity syndrome <strong>in</strong>clu<strong>de</strong> all of the follow<strong>in</strong>g EXCEPT:<br />

a. an XY gonad<br />

b. a vag<strong>in</strong>al pouch<br />

c. breast <strong>de</strong>velopment<br />

d. pubic hair<br />

e. the presence of mullerian-<strong>in</strong>hibit<strong>in</strong>g factor<br />

d<br />

78. Papilomavirus <strong>in</strong>fection is the causative factor of:<br />

a. <strong>in</strong>fertility<br />

b. acute salp<strong>in</strong>gitis<br />

c. cervical cancer<br />

d. ectopic pregnancy<br />

e. endometrio<strong>si</strong>s<br />

c


79. Choose the most appropriate treatment for Trichomonas vag<strong>in</strong>alis <strong>in</strong>fection:<br />

a. penicill<strong>in</strong><br />

b. metronidasole<br />

c. doxycicil<strong>in</strong>e<br />

d. ceftriaxone<br />

e. ampicill<strong>in</strong>e<br />

b<br />

80. Choose the most appropriate treatment for bacterial vag<strong>in</strong>o<strong>si</strong>s:<br />

a. Penicill<strong>in</strong><br />

b. Metronidasole<br />

c. Doxycicil<strong>in</strong>e<br />

d. Ceftriaxone<br />

e. Ampicill<strong>in</strong>e<br />

b<br />

81. Choose the most appropriate treatment for Neiseria gonorrhea <strong>in</strong>fection:<br />

a. Penicill<strong>in</strong><br />

b. Metronidasole<br />

c. Doxycicil<strong>in</strong>e<br />

d. Ceftriaxone<br />

e. Ampicill<strong>in</strong>e<br />

d<br />

82. Choose the most appropriate treatment for syphilis:<br />

a. Penicill<strong>in</strong><br />

b. Metronidasole<br />

c. Doxycicil<strong>in</strong>e<br />

d. Ceftriaxone<br />

e. Ampicill<strong>in</strong>e<br />

a<br />

83. Select the most appropriate therapy for congenital adrenal hyperp<strong>la</strong><strong>si</strong>a<br />

a. estrogens and progest<strong>in</strong>s<br />

b. hydrocortisone<br />

c. progest<strong>in</strong>s<br />

d. prostag<strong>la</strong>nd<strong>in</strong> <strong>in</strong>hibitors<br />

e. none of the above<br />

b<br />

84. What is the cariotype <strong>in</strong> Turner’s syndrome<br />

a. X0<br />

b. XX<br />

c. XY<br />

d. XXY<br />

e. XYY


a<br />

85. Cariotype X0, absence of secondary sexual characteristics, primary amenorrhea, short stature, somatic<br />

abnormalities. Diagno<strong>si</strong>s?<br />

a. Kallman’s syndrome<br />

b. Morris’s syndrome<br />

c. Kl<strong>in</strong>efelter’s syndrome<br />

d. Turner’s syndrome<br />

e. Cush<strong>in</strong>g’s syndrome<br />

d<br />

86. Cariotype XY, normal breast <strong>de</strong>velopment, absence of pubic hear, amenorrhea, male gonads, vag<strong>in</strong>al<br />

pouch. Diagno<strong>si</strong>s?<br />

a. Kallman’s syndrome<br />

b. Morris’s syndrome<br />

c. Kl<strong>in</strong>efelter’s syndrome<br />

d. Turner’s syndrome<br />

e. Cush<strong>in</strong>g’s syndrome<br />

b<br />

87. All of the follow<strong>in</strong>g are contra<strong>in</strong>dications to postmenopausal estrogen rep<strong>la</strong>cement therapy EXCEPT<br />

a. hyperten<strong>si</strong>on<br />

b. acute liver disease<br />

c. familial history of thromboembolic events<br />

d. pelvic re<strong>la</strong>xation<br />

e. premenopausal mastectomy for breast cancer<br />

d<br />

88. Risk factors for cervical cancer are the follow<strong>in</strong>g EXCEPT:<br />

a. first <strong>in</strong>tercourse dur<strong>in</strong>g adolescent years<br />

b. multiple sexual partners<br />

c. cigarette smok<strong>in</strong>g<br />

d. yearly menopause<br />

e. immunosuppres<strong>si</strong>on, <strong>in</strong>clud<strong>in</strong>g HIV <strong>in</strong>fection<br />

d<br />

89. Most circu<strong>la</strong>t<strong>in</strong>g testosterone <strong>in</strong> women is <strong>de</strong>rived from which of the follow<strong>in</strong>g sources?<br />

a. fat<br />

b. ovary<br />

c. sk<strong>in</strong><br />

d. adrenal g<strong>la</strong>nd<br />

e. muscle<br />

d<br />

90. The most frequent category of ovarian tumors are:


a<br />

a. epithelial tumors<br />

b. sex cord stromal neop<strong>la</strong>sms<br />

c. germ cell tumors<br />

d. teratomas<br />

e. endo<strong>de</strong>rmal <strong>si</strong>nus tumors<br />

91. Select the most appropriate therapy for dysmenorrhea<br />

a. clomiphene citrate<br />

b. hydrocortisone<br />

c. progest<strong>in</strong>s<br />

d. prostag<strong>la</strong>nd<strong>in</strong> <strong>in</strong>hibitors<br />

e. none of the above<br />

d<br />

92. Colposcopy is a method of diagno<strong>si</strong>ng pathology of:<br />

a. ovary<br />

b. fallopian tubes<br />

c. cervix<br />

d. uterus<br />

e. vulva<br />

c<br />

93. Which of the follow<strong>in</strong>g is a typical symptom associated with an abnormally en<strong>la</strong>rged 6- to 8-week<br />

myomatous uterus?<br />

a. acute crampy pa<strong>in</strong><br />

b. ur<strong>in</strong>ary frequency<br />

c. constipation<br />

d. ur<strong>in</strong>ary retention<br />

e. none of the above<br />

e<br />

COMPLEMENT MULTIPLU<br />

94. Which of the follow<strong>in</strong>g may be an early warn<strong>in</strong>g <strong>si</strong>gh of preec<strong>la</strong>mp<strong>si</strong>a?<br />

a. weight ga<strong>in</strong> dur<strong>in</strong>g the <strong>la</strong>st months of pregnancy<br />

b. generalized e<strong>de</strong>ma especially of the face<br />

c. leg cramps<br />

d. e<strong>de</strong>ma of the feet at the end of the day<br />

e. pa<strong>in</strong> on pas<strong>si</strong>ng ur<strong>in</strong>e<br />

a, b<br />

95. What are important <strong>si</strong>ghs of magne<strong>si</strong>um sulphate over-dosage?<br />

a. respiratory <strong>de</strong>pres<strong>si</strong>on


. hyperventi<strong>la</strong>tion<br />

c. a ur<strong>in</strong>e output of less than 30 ml per hour<br />

d. <strong>de</strong>pressed tendon reflexes<br />

e. tachycardia<br />

a, d<br />

96. Which of the follow<strong>in</strong>g women has high risk of preec<strong>la</strong>mp<strong>si</strong>a?<br />

a. a patient with a history of preec<strong>la</strong>mp<strong>si</strong>a start<strong>in</strong>g early <strong>in</strong> the third trimester of a previous<br />

pregnancy<br />

b. a patient with chronic hyperten<strong>si</strong>on<br />

c. gran<strong>de</strong> multiparas<br />

d. tw<strong>in</strong> pregnancy<br />

e. a patient with a history of postpartum hemorrhage<br />

a, b, d<br />

97. Which of the follow<strong>in</strong>g patients are at <strong>in</strong>creased risk of p<strong>la</strong>centa praevia?<br />

a. patients with multiple abortions<br />

b. nuliparas<br />

c. patients with <strong>in</strong>tra-uter<strong>in</strong>e fetal growth retardation<br />

d. patients who smoke<br />

e. patients with a history of premature <strong>de</strong>livery<br />

a, d<br />

98. Vag<strong>in</strong>al bleed<strong>in</strong>g due to p<strong>la</strong>centa praevia is usually associated with:<br />

a. fetal parts that are difficult to feel and an absent fetal heart beat<br />

b. fetal head not engaged<br />

c. a uterus that is re<strong>la</strong>xed and not ten<strong>de</strong>r on palpation<br />

d. lower abdom<strong>in</strong>al pa<strong>in</strong><br />

e. bright red color of the blood<br />

b, c, e<br />

99. Choose the correct statements regard<strong>in</strong>g chorioamnionitis:<br />

a. it causes all cases of preterm <strong>la</strong>bor<br />

b. it usually follows preterm rupture of membranes<br />

c. should be treated with comb<strong>in</strong>ation of antibiotics<br />

d. it only occurs <strong>in</strong> patients with vag<strong>in</strong>itis<br />

e. the most frequent <strong>si</strong>gn is backache<br />

b, c<br />

100. Which complications are common if diabetes is not well <strong>control</strong>led?<br />

a. fetal macrosomia


. preec<strong>la</strong>mp<strong>si</strong>a<br />

c. oligohydramnios<br />

d. polihydramnios<br />

e. premature <strong>de</strong>livery<br />

a, b, d<br />

7. Cl<strong>in</strong>ical criteria of chorioamnionitis <strong>in</strong>clu<strong>de</strong>:<br />

a. headache and backache<br />

b. vag<strong>in</strong>al bleed<strong>in</strong>g<br />

c. fetal tachycardia<br />

d. purulent vag<strong>in</strong>al discharge<br />

e. fever more than 38C<br />

c, d, e<br />

101. Which patients are at high risk of preterm <strong>la</strong>bor?<br />

a. patients who book early <strong>in</strong> pregnancy<br />

b. patents with tw<strong>in</strong> pregnancy<br />

c. patients liv<strong>in</strong>g <strong>in</strong> low socio-economic circumstances<br />

d. patients with bacterial vag<strong>in</strong>o<strong>si</strong>s<br />

e. patients with a history of preterm <strong>la</strong>bor <strong>in</strong> previous pregnancy<br />

b, c, d, e<br />

102. Management of patient with premature pre<strong>la</strong>bor rupture of membranes <strong>in</strong>clu<strong>de</strong>:<br />

a. bimanual exploration of the cervix<br />

b. prophy<strong>la</strong>ctic adm<strong>in</strong>istration of antibiotics<br />

c. adm<strong>in</strong>istration of corticosteroids<br />

d. transfer to a maternity with neonatological <strong>in</strong>ten<strong>si</strong>ve care unit<br />

e. estimation of gestational age as accurate as pos<strong>si</strong>ble<br />

b, c, d, e<br />

103. How should the fetal heart rate be monitored <strong>in</strong> <strong>la</strong>bor?<br />

a. a cardiotocograph (CTG) should be used <strong>in</strong> high risk <strong>la</strong>bors<br />

b. <strong>in</strong> low risk pregnancies a fetal stethoscope is a<strong>de</strong>quate<br />

c. a doptone should be used <strong>in</strong> all high risk pregnancies<br />

d. the fetal heart rate does not need to be monitored <strong>in</strong> all low risk pregnancies<br />

e. if admis<strong>si</strong>on CTG is normal, fetal heart rate should not be monitored <strong>in</strong> <strong>la</strong>bor<br />

a, b<br />

104. Which of the follow<strong>in</strong>g are contra<strong>in</strong>dications to giv<strong>in</strong>g syntometr<strong>in</strong>e dur<strong>in</strong>g the third<br />

stage of <strong>la</strong>bor?<br />

a. an atonic uterus


. hypoten<strong>si</strong>on after <strong>de</strong>livery<br />

c. gestational hyperten<strong>si</strong>on<br />

d. preec<strong>la</strong>mp<strong>si</strong>a<br />

e. fetal macrosomia<br />

c, d<br />

105. Which drugs are used for prevention of postpartum hemorrhage<br />

a. Oxitoc<strong>in</strong><br />

b. ergometr<strong>in</strong>e<br />

c. calcium gluconate<br />

d. ritodr<strong>in</strong><br />

e. syntometr<strong>in</strong>e<br />

a, b, e<br />

106. Which oxytocic drugs may be given if there is a contra<strong>in</strong>dication to the use of<br />

syntometr<strong>in</strong>e?<br />

a. ergometr<strong>in</strong>e<br />

b. a comb<strong>in</strong>ation of oxytoc<strong>in</strong> and ergometr<strong>in</strong>e<br />

c. oxitoc<strong>in</strong><br />

d. prostag<strong>la</strong>nd<strong>in</strong> E2<br />

e. misoprostol<br />

c, d, e<br />

107. Active management of the third stage of <strong>la</strong>bor <strong>in</strong>clu<strong>de</strong>s follow<strong>in</strong>g components :<br />

a. giv<strong>in</strong>g an oxytocic <strong>in</strong> the first m<strong>in</strong>ute after <strong>de</strong>livery<br />

b. wait<strong>in</strong>g for the <strong>si</strong>gns of p<strong>la</strong>cental separation when the patient is asked to bear<br />

down and spontaneously <strong>de</strong>liver the p<strong>la</strong>centa<br />

c. pull<strong>in</strong>g down steadily on the umbilical cord and push<strong>in</strong>g the uterus up when the<br />

patient has a contraction<br />

d. giv<strong>in</strong>g an oxytocic drug when the <strong>si</strong>gns of p<strong>la</strong>cental separation appear so that the<br />

p<strong>la</strong>centa can be spontaneously <strong>de</strong>livered<br />

e. massage of the uterus after <strong>de</strong>livery of p<strong>la</strong>centa<br />

a, c, e<br />

108. What are <strong>in</strong>frequent causes of postpartum hemorrhage:<br />

a. cervical and vag<strong>in</strong>al tears<br />

b. uter<strong>in</strong>e <strong>in</strong>ver<strong>si</strong>on<br />

c. DIC syndrome<br />

d. Coagulopathy<br />

e. Uter<strong>in</strong>e atonia<br />

b, c, d


109. Which complications are common if diabetes is not well <strong>control</strong>led?<br />

a. Fetal macrosomia<br />

b. Preec<strong>la</strong>mp<strong>si</strong>a<br />

c. oligohydramnios<br />

d. polihydramnios<br />

e. premature <strong>de</strong>livery<br />

a, b, d<br />

110. Normal maternal adjustments <strong>in</strong> pregnancy <strong>in</strong>clu<strong>de</strong>:<br />

a. rise <strong>in</strong> cardiac output<br />

b. hemodilution<br />

c. <strong>de</strong>crease of diastolic pressure<br />

d. <strong>in</strong>crease <strong>in</strong> p<strong>la</strong>sma volume<br />

e. <strong>de</strong>crease <strong>in</strong> red blood cell mass<br />

a, b, c, d<br />

111. The causes of oligohydramnios are:<br />

a. fetal growth retardation<br />

b. renal agene<strong>si</strong>s<br />

c. preec<strong>la</strong>mp<strong>si</strong>a<br />

d. neural tube <strong>de</strong>fects<br />

e. pre<strong>la</strong>bor rupture of membranes<br />

a, b, c, e<br />

96. The causes of polyhydramnios are:<br />

a. maternal diabetes<br />

b. absence of esophagus<br />

c. neural tube <strong>de</strong>fects<br />

d. preec<strong>la</strong>mp<strong>si</strong>a<br />

e. renal agene<strong>si</strong>s<br />

a, b, c<br />

112. The fetus with postmaturity syndrome has the follow<strong>in</strong>g:<br />

a. loss of subcutaneous fat<br />

b. short f<strong>in</strong>gernails<br />

c. dry, peel<strong>in</strong>g sk<strong>in</strong><br />

d. long f<strong>in</strong>gernails<br />

e. abundant vernix caseosa<br />

a, c, d


113. Indications for a cesarean section <strong>in</strong>clu<strong>de</strong>:<br />

a. previous cesarean section<br />

b. p<strong>la</strong>centa previa<br />

c. fetal distress<br />

d. cervical cerc<strong>la</strong>ge<br />

e. cord pro<strong>la</strong>pse<br />

a, b, c, e<br />

114. What is <strong>in</strong>dicated for prevention of respiratory distress syndrome <strong>in</strong> premature neonates:<br />

a. hepar<strong>in</strong><br />

b. oxitoc<strong>in</strong><br />

c. <strong>de</strong>xamethasone<br />

d. magne<strong>si</strong>um sulphate<br />

e. betamethasone<br />

c, e<br />

115. What is <strong>in</strong>dicated to stop premature uter<strong>in</strong>e contractions:<br />

a. ritodr<strong>in</strong><br />

b. oxytoc<strong>in</strong><br />

c. <strong>de</strong>xametazon<br />

d. nifedip<strong>in</strong>e<br />

e. <strong>in</strong>dometac<strong>in</strong>e<br />

a, d, e<br />

116. Atrophic vag<strong>in</strong>itis would be expected <strong>in</strong> the follow<strong>in</strong>g cl<strong>in</strong>ical <strong>si</strong>tuations:<br />

a. menopause<br />

b. oral contraceptive use<br />

c. surgical castration <strong>in</strong> a young woman<br />

d. pseudomenopause dur<strong>in</strong>g endometrio<strong>si</strong>s therapy<br />

e. dysfunctional uter<strong>in</strong>e bleed<strong>in</strong>g<br />

a, c, d<br />

117. Which statements concern<strong>in</strong>g the function of progesterone are correct:<br />

A. it prepares endometrium for nidation<br />

B. it re<strong>la</strong>xes the myometrium<br />

C. it elevates serum b<strong>in</strong>d<strong>in</strong>g prote<strong>in</strong><br />

D. it <strong>in</strong>crease basal body temperature<br />

E. it is secreted by hypotha<strong>la</strong>mus<br />

a, b, d<br />

118. Normal vag<strong>in</strong>al health <strong>de</strong>pends on the follow<strong>in</strong>g factors:<br />

a. a pH of 4.5<br />

b. Do<strong>de</strong>rle<strong>in</strong>’s bacilli


c. Estrogen<br />

d. Escherichia coli<br />

e. Lactic acid production<br />

a, b, c, e<br />

119. The follow<strong>in</strong>g are characteristic for androgen <strong>in</strong>sen<strong>si</strong>tivity syndrome (testicu<strong>la</strong>r fem<strong>in</strong>ization)<br />

a. normal breast <strong>de</strong>velopment<br />

b. absence of pubic hear<br />

c. amenorrhea<br />

d. presents of uterus and tubes<br />

e. male gonads<br />

a, b, c, e<br />

120. Choose drugs used for treatment for Candida vag<strong>in</strong>itis:<br />

a. Penicill<strong>in</strong><br />

b. Miconazol<br />

c. Nistat<strong>in</strong><br />

d. Ketoconazole<br />

e. Metronidazole<br />

b, c, d<br />

121. Amenorrhea <strong>in</strong> a 16-year-old girl may result from the follow<strong>in</strong>g conditions<br />

a. imperforate hymen<br />

b. androgen <strong>in</strong>sen<strong>si</strong>tivity syndrome<br />

c. Turner’s syndrome<br />

d. granulosa-theca cell tumor<br />

e. estrogen produc<strong>in</strong>g tumor<br />

a, b, c<br />

122. What are the characteristics of follicu<strong>la</strong>r phase:<br />

a. variable length<br />

b. an elevated basal body temperature<br />

c. <strong>de</strong>velopment of ovarian follicles<br />

d. secretion of estrogen from the ovary<br />

e. vascu<strong>la</strong>r growth of the endometrium<br />

a, c, d, e<br />

123. Factors that are important <strong>in</strong> the pathophy<strong>si</strong>ology of pelvic <strong>in</strong>f<strong>la</strong>mmatory disease <strong>in</strong>clu<strong>de</strong>:<br />

a. <strong>in</strong>trauter<strong>in</strong>e <strong>de</strong>vice use<br />

b. <strong>in</strong>tercourse<br />

c. menstruation<br />

d. pregnancy term<strong>in</strong>ation<br />

e. uter<strong>in</strong>e fibroids<br />

a, b, c, d


124. Which the follow<strong>in</strong>g are characteristics of lutheal phase:<br />

a. a fairly constant duration of 12-16 days<br />

b. a <strong>de</strong>creased basal body temperature<br />

c. the formation of corpus luteum of the ovary<br />

d. secretion of progesterone<br />

e. <strong>de</strong>velopment of dom<strong>in</strong>ant follicle<br />

a, c, d<br />

125. Which statements are <strong>in</strong>correct:<br />

a. FSH stimu<strong>la</strong>tes follicu<strong>la</strong>r growth<br />

b. GhRH is secreted <strong>in</strong> a pulsatile manner<br />

c. LH stimu<strong>la</strong>tes secretion of estrogens by granulosa cells<br />

d. GhRH stimu<strong>la</strong>tes synthe<strong>si</strong>s and release of both FSH and LH<br />

e. Progesterone <strong>de</strong>crease basal body temperature<br />

c, e<br />

126. Phy<strong>si</strong>ologic changes effected by oral contraceptives <strong>in</strong>clu<strong>de</strong>:<br />

A. suppres<strong>si</strong>on of ovu<strong>la</strong>tion<br />

B. hostile cervical mucus<br />

C. a hypo-estrogenic state<br />

D. <strong>in</strong>active endometrium<br />

E. <strong>in</strong>crease of gonadotrop<strong>in</strong>s<br />

a, b, d<br />

127. Which diseases and consequences are produced by Ch<strong>la</strong>midia trachomatis <strong>in</strong>fection:<br />

a. acute salp<strong>in</strong>gitis<br />

b. ectopic pregnancy<br />

c. muco-purulent cervicitis<br />

d. cervical cancer<br />

e. urethritis<br />

a, b, c, e<br />

128. The etiologic factors of vulvovag<strong>in</strong>itis are:<br />

a. Candida<br />

b. Trichomonus<br />

c. Lack of estrogens<br />

d. Neiseria gonorrhea<br />

e. Ch<strong>la</strong>midia trachomatis<br />

a, b, c<br />

129. The symptoms and <strong>si</strong>gns of polycystic ovary disease are:<br />

a. obe<strong>si</strong>ty<br />

b. <strong>in</strong>fertility<br />

c. hyrsutism<br />

d. polymenorrhea


e. <strong>in</strong>creased volume of ovaries<br />

a, b, c, e<br />

130. Choose drugs used for treatment for Ch<strong>la</strong>midia trachomatis <strong>in</strong>fection:<br />

a. penicill<strong>in</strong><br />

b. metronidasole<br />

c. doxycicil<strong>in</strong>e<br />

d. ceftriaxone<br />

e. eritromic<strong>in</strong>e<br />

c, e<br />

131. Which are the characteristics of Turner ‘s syndrome<br />

a. cariotype X0<br />

b. primary amenorrhea<br />

c. somatic abnormalities<br />

d. <strong>in</strong>creased levels of estrogens<br />

e. <strong>in</strong>creased levels of gonadotrop<strong>in</strong>s<br />

a, b, c, e<br />

132. Select the options for treatment for dysfunctional uter<strong>in</strong>e bleed<strong>in</strong>g<br />

a. estrogens and progest<strong>in</strong>s<br />

b. hydrocortisone<br />

c. progest<strong>in</strong>s<br />

d. prostag<strong>la</strong>nd<strong>in</strong> <strong>in</strong>hibitors<br />

e. vacuum aspiration<br />

a, c, e<br />

133. The follow<strong>in</strong>g hormones are produced <strong>in</strong> anterior pituitary:<br />

a. FSH<br />

b. Pro<strong>la</strong>ct<strong>in</strong><br />

c. LH<br />

d. Vasopre<strong>si</strong>n<br />

e. TSH<br />

a, b, c, e<br />

134. The occurrence of menstruation is <strong>de</strong>pen<strong>de</strong>nt upon the follow<strong>in</strong>g factors:<br />

a. gonadotrop<strong>in</strong>-relea<strong>si</strong>ng hormone (GhRH)<br />

b. an endometrium respon<strong>si</strong>ve to sex steroids<br />

c. gonadotrop<strong>in</strong>s<br />

d. patent fallopian tubes<br />

e. ovarian steroidal hormones<br />

a, b, c, e


135. Procedures for treatment of cervical dysp<strong>la</strong><strong>si</strong>as are:<br />

a. electrocautery<br />

b. cryotherapy<br />

c. <strong>la</strong>paroscopy<br />

d. cold coagu<strong>la</strong>tion<br />

e. <strong>la</strong>ser vaporization<br />

a, b, d, e<br />

136. Risk factor for endometrial cancer are:<br />

a. obe<strong>si</strong>ty<br />

b. chronic anovu<strong>la</strong>tion/polycystic ovary disease<br />

c. first <strong>in</strong>tercourse dur<strong>in</strong>g adolescent years<br />

d. <strong>la</strong>te menopause<br />

e. exogenous unopposed estrogen<br />

a, b, d, e<br />

137. Ovarian tumors produc<strong>in</strong>g hormones are:<br />

a. granulosa cell tumors<br />

b. theca cell tumors<br />

c. Sertoli-Leidig cell tumors<br />

d. endometriod tumors<br />

e. gonadob<strong>la</strong>stoma<br />

a, b, c, e<br />

138. Elevated gonadotrop<strong>in</strong> levels are expected with which of the follow<strong>in</strong>g conditions associated with<br />

amenorrhea?<br />

A. Rokitansky-Kuster-Hauser syndrome<br />

B. Re<strong>si</strong>stant ovary syndrom<br />

C. Gonadal dysgene<strong>si</strong>s<br />

D. Anorexia nervosa<br />

E. Pituitary a<strong>de</strong>noma<br />

b, c<br />

139. An <strong>in</strong>creased <strong>in</strong>ci<strong>de</strong>nce of ectopic pregnancy has been associated with the follow<strong>in</strong>g:<br />

a. Endometrio<strong>si</strong>s<br />

b. Chronic salp<strong>in</strong>gitis<br />

c. A<strong>de</strong>nomyo<strong>si</strong>s<br />

d. Use of <strong>in</strong>trauter<strong>in</strong>e <strong>de</strong>vise (IUD)<br />

e. Oral hormonal contraception<br />

A, b, d<br />

140. Known consequences of pelvic <strong>in</strong>f<strong>la</strong>mmatory disease <strong>in</strong>clu<strong>de</strong>:<br />

a. endometrio<strong>si</strong>s<br />

b. ectopic pregnancy<br />

c. pelvic adhe<strong>si</strong>ons<br />

d. sterility


, c, d<br />

e. ovarian epithelial tumors<br />

141. Which drug comb<strong>in</strong>ations would be appropriate <strong>in</strong> the management of acute pelvic <strong>in</strong>f<strong>la</strong>mmatory<br />

disease:<br />

a. doxycycl<strong>in</strong>e/metronidasole<br />

b. cefoxit<strong>in</strong>/doxycycl<strong>in</strong>e<br />

c. ofloxac<strong>in</strong>e/cl<strong>in</strong>damic<strong>in</strong>e<br />

d. ampicill<strong>in</strong>e/gentamic<strong>in</strong>e<br />

e. penicill<strong>in</strong>e / amoxicill<strong>in</strong>e<br />

a, b, c<br />

142. Submucous myomas may be associated with the follow<strong>in</strong>g <strong>si</strong>gns and symptoms :<br />

a. abnormal bleed<strong>in</strong>g<br />

b. reproductive failure<br />

c. anemia<br />

d. compres<strong>si</strong>on of adjacent organs<br />

e. peduncu<strong>la</strong>ted characteristics<br />

a, b, c, e<br />

143. Defects <strong>in</strong> corpus luteum function may be <strong>de</strong>monstrated by the follow<strong>in</strong>g procedures:<br />

a. measurement of basal body temperature<br />

b. endometrial byopsy and histology dat<strong>in</strong>g<br />

c. measurement of serum progesterone levels<br />

d. measurement of serum estrogen levels<br />

e. measurement of FSH/LH levels<br />

a, b, c<br />

144. Which procedures are appropriate for evaluation of the endometrial cavity<br />

a. <strong>la</strong>paroscopy<br />

b. endometrial biopsy<br />

c. hysterescopy<br />

d. colposcopy<br />

e. hysterography<br />

b, c, e<br />

145. Therapy for the correction of a cervical factor <strong>in</strong> <strong>in</strong>fertility <strong>in</strong>clu<strong>de</strong>s the follow<strong>in</strong>g:<br />

a. <strong>in</strong>trauter<strong>in</strong>e <strong>in</strong>sem<strong>in</strong>ation<br />

b. progesterone <strong>in</strong> the second phase of menstrual cycle<br />

c. antibiotics<br />

d. human chorionic gonadotrop<strong>in</strong> (hCG) <strong>in</strong>jection<br />

e. <strong>in</strong> vitro fertilization and embryo transfer<br />

a, c, e


146. Which factors are evi<strong>de</strong>nce that ovu<strong>la</strong>tion occurred:<br />

a. a rise <strong>in</strong> basal body temperature<br />

b. estrogen level above 25 mcg/ml<br />

c. progesterone level above 3 ng/ml<br />

d. secretory endometrium<br />

e. the occurrence of menses<br />

a, c, d<br />

147. A poor postcoital test can be reflective of the follow<strong>in</strong>g:<br />

a. blocked fallopian tubes<br />

b. low sperm count<br />

c. poor sperm motility<br />

d. poor cervical mucus<br />

e. low level of gonadotrop<strong>in</strong>s<br />

b, c, d<br />

148. Myomas are associated with the follow<strong>in</strong>g cl<strong>in</strong>ical conditions:<br />

a. anemia<br />

b. dysuria<br />

c. low vag<strong>in</strong>al pH<br />

d. dysmenorrhea<br />

e. amenorrhea<br />

a, b, d<br />

149. Abnormalities <strong>in</strong> the cervical mucus may result from the follow<strong>in</strong>g conditions:<br />

a. colonization of the cervix with cytotoxic organisms<br />

b. uter<strong>in</strong>e retrover<strong>si</strong>on<br />

c. chronic <strong>in</strong>fection of the cervix<br />

d. previous electro-cauterization of the cervix<br />

e. anti-sperm antibodies<br />

a, c, d, e<br />

150. Bacterial vag<strong>in</strong>o<strong>si</strong>s is diagnosed based on follow<strong>in</strong>g features:<br />

a. a pH of 6.0<br />

b. “clue” cells<br />

c. a pH

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!